---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-137800"
form_type: "8-K"
ticker: "PHAT"
cik: "0001783183"
company_name: "Phathom Pharmaceuticals, Inc."
filed_at: "2025-06-09T23:59:59+00:00"
generated_at: "2026-05-19T17:24:45.615246+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# PHAT shareholders elect two directors, ratify EY, approve say-on-pay at annual meeting

## Summary
- Heidi Kunz elected Class III director with 34,023,182 for, 451,384 withheld; James Topper with 26,884,171 for, 7,590,395 withheld.
- Ernst & Young LLP ratified as auditor for fiscal 2025: 51,670,346 for, 177,785 against, 53,817 abstentions.
- Say-on-pay approved on non-binding advisory basis: 24,584,781 for, 8,704,739 against, 1,185,046 abstentions, 17,427,382 broker non-votes.
- Say-on-frequency set to every 1 year with 30,665,967 votes for, 21,543 for 2 years, 2,611,188 for 3 years, 1,175,868 abstentions.
- Company will hold annual advisory votes on executive compensation until next required say-on-pay vote.

## SEC filing metadata
- accession: 0001193125-25-137800
- form_type: 8-K
- ticker: PHAT
- cik: 0001783183
- company_name: Phathom Pharmaceuticals, Inc.
- filed_at: 2025-06-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1783183/000119312525137800/0001193125-25-137800-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1783183/000119312525137800/d95460d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-137800
- JSON: https://secwatch.observer/filing/0001193125-25-137800.json
- Plain text: https://secwatch.observer/filing/0001193125-25-137800.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.